Nutex Health, Inc. (NUTX) 10-Year Financial Performance & Capital Metrics

NUTX • • Industrial / General

HealthcareHealthcare ITClinical Software & EHR SystemsElectronic Health Record Systems

AboutNutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.Show more

Revenue $480M +93.8%
EBITDA $150M +1154.8%
Net Income $52M +214.0%
EPS (Diluted) 9.71 +193.5%
Gross Margin 40.89% +191.2%
EBITDA Margin 31.17% +644.3%
Operating Margin 27.22% +312.1%
Net Margin 10.87% +158.8%
ROE 37.14% +180.9%
ROIC 23.56% +439.2%
Debt/Equity 1.69 -51.6%
Interest Coverage 6.55 +436.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 20.1%
✓Strong Piotroski F-Score: 7/9
✓Momentum leader: RS Rating 90 (top 10%)
✓Strong 5Y sales CAGR of 37.7%

✗Weaknesses

✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 15.7% in last year

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y68.85%

5Y37.67%

3Y13.12%

TTM236.03%

Profit (Net Income) CAGR

10Y-

5Y20.05%

3Y-26.72%

TTM377.31%

EPS CAGR

10Y-

5Y19.53%

3Y-33.85%

TTM296.53%

ROCE

10Y Avg-41%

5Y Avg8.87%

3Y Avg-29.7%

Latest30.58%

Peer Comparison

Electronic Health Record Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OMCLOmnicell, Inc.	2.29B	50.98	188.81	-3.04%	1.69%	1.63%	6.61%	0.31
NUTXNutex Health, Inc.	1.16B	164.21	16.91	93.8%	11.63%	26.04%	1.8%	1.69
SYSo-Young International Inc.	222.7M	2.65	-0.60	-2.09%	-51.75%	-41.37%		0.12
CCLDCareCloud, Inc.	120.83M	2.85	-10.18	-5.32%	9.8%	19.39%	15.68%	0.07
PHRPhreesia, Inc.	991.72M	16.45	-16.13	17.83%	-1.16%	-1.68%	0.84%	0.07

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	53.65K	91.37K	97.06M	274.03M	331.53M	219.29M	247.65M	479.95M
Revenue Growth %	-1%	-	-	0.7%	1061.21%	1.82%	0.21%	-0.34%	0.13%	0.94%
Cost of Goods Sold+	662	473	564.37K	62.3K	0	116.42M	152.25M	203.87M	212.87M	283.69M
COGS % of Revenue	-	-	10.52%	0.68%	-	0.42%	0.46%	0.93%	0.86%	0.59%
Gross Profit+	-662	-473	-510.72K	29.07K	97.06M	157.61M	179.28M	15.42M	34.77M	196.26M
Gross Margin %	-	-	-9.52%	0.32%	1%	0.58%	0.54%	0.07%	0.14%	0.41%
Gross Profit Growth %	-1%	0.29%	-1078.75%	1.06%	3337.16%	0.62%	0.14%	-0.91%	1.25%	4.64%
Operating Expenses+	532.33K	448.12K	5.69M	1.8M	62.35M	4.43M	9.02M	422.02M	66.55M	65.64M
OpEx % of Revenue	-	-	105.98%	19.67%	0.64%	0.02%	0.03%	1.92%	0.27%	0.14%
Selling, General & Admin	532.33K	448.12K	1.81M	1.16M	59.87M	4.43M	5.46M	20M	36.07M	58.56M
SG&A % of Revenue	-	-	33.81%	12.74%	0.62%	0.02%	0.02%	0.09%	0.15%	0.12%
Research & Development	0	0	25.64K	545.22K	0	0	285.88K	0	0	0
R&D % of Revenue	-	-	0.48%	5.97%	-	-	0%	-	-	-
Other Operating Expenses	0	0	3.87M	633.57K	2.48M	0	3.27M	402.02M	30.48M	7.08M
Operating Income+	-532.99K	-448.6K	-5.69M	-1.83M	34.71M	153.17M	170.26M	-406.6M	-31.77M	130.62M
Operating Margin %	-	-	-106.12%	-20.03%	0.36%	0.56%	0.51%	-1.85%	-0.13%	0.27%
Operating Income Growth %	0.37%	0.16%	-11.69%	0.68%	19.96%	3.41%	0.11%	-3.39%	0.92%	5.11%
EBITDA+	-532.33K	-448.13K	-5.16M	-1.83M	37.19M	159.07M	178.02M	-393.47M	-14.18M	149.59M
EBITDA Margin %	-	-	-96.15%	-20.03%	0.38%	0.58%	0.54%	-1.79%	-0.06%	0.31%
EBITDA Growth %	0.37%	0.16%	-10.51%	0.65%	21.32%	3.28%	0.12%	-3.21%	0.96%	11.55%
D&A (Non-Cash Add-back)	662	473	535.02K	522	2.48M	5.9M	7.76M	13.13M	17.59M	18.97M
EBIT	-532.98K	-448.48K	-5.64M	-840.33K	35.62M	152.17M	175.69M	-407.16M	-32.17M	129.68M
Net Interest Income+	-3.14K	-2.46K	0	0	-3.53M	-6.43M	-6.2M	-12.49M	-16.32M	-19.93M
Interest Income	4	114	0	0	0	0	0	0	0	0
Interest Expense	3.15K	2.58K	-367.35K	-642.07K	3.53M	6.43M	6.2M	12.49M	16.32M	19.93M
Other Income/Expense	-3.14K	-2.46K	-314.55K	-983.68K	-2.62M	-7.43M	-773.88K	-13.05M	-16.72M	-20.87M
Pretax Income+	-536.13K	-451.06K	582.06K	-2.81M	32.09M	145.74M	169.49M	-419.65M	-48.49M	109.75M
Pretax Margin %	-	-	10.85%	-30.8%	0.33%	0.53%	0.51%	-1.91%	-0.2%	0.23%
Income Tax+	0	0	-535.02K	-161.14K	0	181.34K	965.73K	13.09M	-5.07M	14.48M
Effective Tax Rate %	-0.16%	16.48%	1%	1%	0.65%	0.73%	0.78%	1.01%	0.94%	0.48%
Net Income+	83.81K	-7.43M	582.06K	-2.81M	20.92M	105.97M	132.59M	-424.78M	-45.79M	52.18M
Net Margin %	-	-	10.85%	-30.8%	0.22%	0.39%	0.4%	-1.94%	-0.18%	0.11%
Net Income Growth %	1.22%	-89.68%	1.08%	-5.83%	8.43%	4.06%	0.25%	-4.2%	0.89%	2.14%
Net Income (Continuing)	-536.13K	-451.06K	-6.01M	-950.13K	32.09M	145.56M	168.53M	-432.74M	-43.42M	95.27M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	22.53M	61.56M	76.93M	24.46M	17.65M	55.55M
EPS (Diluted)+	0.04	-3.60	0.14	-0.39	3.98	24.69	33.55	-100.36	-10.39	9.71
EPS Growth %	1.13%	-89.67%	1.04%	-3.79%	11.21%	5.2%	0.36%	-3.99%	0.9%	1.93%
EPS (Basic)	0.04	-3.60	0.14	-0.39	3.98	24.69	33.55	-100.50	-10.39	10.23
Diluted Shares Outstanding	2.07M	2.07M	4.18M	7.18M	4.14M	4.29M	3.95M	4.23M	4.41M	5.1M
Basic Shares Outstanding	2.07M	2.07M	4.18M	7.18M	4.14M	4.29M	4.02M	4.23M	4.41M	5.1M
Dividend Payout Ratio	-	-	-	-	0.9%	0.56%	1.09%	-	-	0.12%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	7.63M	507.93K	55.08K	305.42K	45.74M	135.51M	154.02M	97.97M	90.85M	292.48M
Cash & Short-Term Investments	122.29K	10.52K	9.45K	119.27K	8M	25.51M	36.12M	34.26M	22M	43.58M
Cash Only	122.29K	10.52K	9.45K	119.27K	8M	25.51M	36.12M	34.26M	22M	43.58M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	0	15K	6.25K	186.15K	36.14M	108.14M	114.76M	58.32M	62.78M	236.05M
Days Sales Outstanding	-	-	42.55	743.6	135.91	144.04	126.34	97.06	92.52	179.52
Inventory	0	0	0	27.07K	899.91K	1.73M	2.81M	3.53M	3.39M	2.85M
Days Inventory Outstanding	-	-	-	158.62	-	5.41	6.75	6.33	5.81	3.67
Other Current Assets	7.27M	482.41K	39.38K	-27.07K	0	0	323.28K	1.87M	0	10M
Total Non-Current Assets+	3.38K	2.9K	3.27M	144.01K	133.48M	173.05M	240.63M	333.78M	307.4M	362.84M
Property, Plant & Equipment	1.66K	1.18K	3.85K	7.61K	131.28M	170.81M	238.36M	295.15M	269.39M	324.69M
Fixed Asset Turnover	-	-	13.95x	12.00x	0.74x	1.60x	1.39x	0.74x	0.92x	1.48x
Goodwill	0	0	0	0	3.47M	1.14M	1.14M	17.01M	17.07M	13.92M
Intangible Assets	0	0	3.27M	2.57M	1.54M	0	682.65K	21.19M	20.51M	15.53M
Long-Term Investments	0	0	0	116.96K	100K	0	0	0	0	0
Other Non-Current Assets	1.72K	1.72K	1.95K	19.43K	-2.81M	1.1M	456.08K	423.43K	431.13K	711.35K
Total Assets+	7.64M	510.83K	3.33M	449.43K	179.22M	308.55M	394.65M	431.75M	398.25M	655.32M
Asset Turnover	-	-	0.02x	0.20x	0.54x	0.89x	0.84x	0.51x	0.62x	0.73x
Asset Growth %	2.68%	-0.93%	5.52%	-0.86%	397.78%	0.72%	0.28%	0.09%	-0.08%	0.65%
Total Current Liabilities+	6.08M	6.38M	959.78K	1.04M	72.13M	31.45M	37.69M	54.86M	58.31M	140.87M
Accounts Payable	168.97K	356K	348.35K	567.01K	1.75M	8.63M	17.65M	23.93M	25.28M	13.96M
Days Payables Outstanding	93.16K	274.72K	225.3	3.32K	-	27.06	42.32	42.84	43.35	17.96
Short-Term Debt	0	50K	386.19K	477.06K	13.35M	18.65M	10.23M	15.17M	14.18M	17.95M
Deferred Revenue (Current)	811.23K	0	9.1K	9.19K	165.56K	38.65K	173.92K	0	0	0
Other Current Liabilities	5.1M	5.97M	216.14K	332.19K	3.37M	-38.65K	3.6M	5.61M	0	0
Current Ratio	1.26x	0.08x	0.06x	0.29x	0.63x	4.31x	4.09x	1.79x	1.56x	2.08x
Quick Ratio	1.26x	0.08x	0.06x	0.27x	0.62x	4.25x	4.01x	1.72x	1.50x	2.06x
Cash Conversion Cycle	-	-	-	-2.42K	-	122.39	90.77	60.55	54.99	165.22
Total Non-Current Liabilities+	0	0	0	902.72K	56.26M	129.73M	165.38M	256.56M	260.83M	312.56M
Long-Term Debt	0	0	0	902.72K	40.88M	81.9M	78.82M	23.05M	26.31M	22.47M
Capital Lease Obligations	0	0	0	0	15.38M	47.83M	86.56M	223.06M	229.37M	290.1M
Deferred Tax Liabilities	0	0	0	0	0	0	1.75M	10.45M	5.15M	0
Other Non-Current Liabilities	0	0	0	0	0	0	-1.75M	0	0	0
Total Liabilities	6.08M	6.38M	959.78K	1.95M	128.39M	161.19M	203.07M	311.42M	319.14M	453.43M
Total Debt+	0	50K	386.19K	1.38M	119.94M	150.12M	178.55M	267.2M	275.76M	340.3M
Net Debt	-122.29K	39.48K	376.74K	1.26M	111.94M	124.61M	142.43M	232.95M	253.75M	296.72M
Debt / Equity	-	-	0.16x	-	2.36x	1.02x	0.93x	2.22x	3.49x	1.69x
Debt / EBITDA	-	-	-	-	3.23x	0.94x	1.00x	-	-	2.27x
Net Debt / EBITDA	-	-	-	-	3.01x	0.78x	0.80x	-	-	1.98x
Interest Coverage	-169.42x	-173.94x	-	-	9.83x	23.81x	27.48x	-32.55x	-1.95x	6.55x
Total Equity+	1.56M	-5.87M	2.37M	-1.5M	50.84M	147.37M	191.58M	120.33M	79.11M	201.89M
Equity Growth %	-0.03%	-4.76%	1.4%	-1.63%	34.95%	1.9%	0.3%	-0.37%	-0.34%	1.55%
Book Value per Share	0.76	-2.84	0.57	-0.21	12.28	34.34	48.48	28.43	17.94	39.59
Total Shareholders' Equity	1.56M	-5.87M	2.37M	-1.5M	28.31M	85.81M	114.65M	95.86M	61.45M	146.34M
Common Stock	39.68K	39.71K	126.2K	1.77K	4.65K	5.28K	592.79K	650.22K	676.68K	5.51K
Retained Earnings	-2.8M	-10.23M	-9.65M	-5.45M	-12.57M	-18.22M	102.32M	-363.29M	-409.07M	-356.89M
Treasury Stock	0	0	-1M	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	22.53M	61.56M	76.93M	24.46M	17.65M	55.55M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	44.91K	-274.22K	-714.62K	-480.05K	12.12M	86.67M	173.43M	50.61M	1.26M	23.15M
Operating CF Margin %	-	-	-13.32%	-5.25%	0.12%	0.32%	0.52%	0.23%	0.01%	0.05%
Operating CF Growth %	1.07%	-7.11%	-1.61%	0.33%	26.26%	6.15%	1%	-0.71%	-0.98%	17.43%
Net Income	-536.13K	-451.06K	-6.01M	-950.13K	32.09M	145.56M	168.53M	-432.74M	-43.42M	95.27M
Depreciation & Amortization	662	473	535.02K	522	2.48M	5.96M	7.66M	13.13M	17.59M	18.97M
Stock-Based Compensation	0	0	924.33K	208.03K	0	0	0	189.58K	2.84M	16.63M
Deferred Taxes	0	0	-115.22K	-123.43K	0	0	0	5M	-5.71M	-13.13M
Other Non-Cash Items	563.79K	-316.72K	5.52M	-160.67K	-596.94K	1.18M	-5.51M	400.71M	31.62M	9.81M
Working Capital Changes	-116.58K	307K	193.65K	310.99K	-21.85M	-66.02M	2.75M	64.32M	-1.66M	-104.4M
Change in Receivables	56.7K	0	-4K	-82.09K	-24.74M	-71.23M	-6.62M	58.08M	-4.58M	-173.41M
Change in Inventory	0	0	0	127	-486.27K	-825.77K	-1.09M	-719.11K	142.7K	540.77K
Change in Payables	77.79K	187.03K	119.22K	402.25K	1.63M	6.23M	6.27M	9.69M	-2.25M	-10.72M
Cash from Investing+	1.83K	-9.99K	2.05K	-116.96K	-31.23M	-61.19M	-36.98M	-4.34M	-11.24M	-2.67M
Capital Expenditures	0	0	0	0	-32.28M	-61.19M	-36.93M	-14.63M	-9.5M	-2.3M
CapEx % of Revenue	-	-	-	-	0.33%	0.22%	0.11%	0.07%	0.04%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	1.83K	-9.99K	32.85K	0	0	0	0	0	0	0
Cash from Financing+	-51.28K	172.44K	711.5K	704.57K	21.71M	-7.97M	-125.85M	-48.13M	-2.27M	1.09M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	-18.9M	-59.05M	-144.34M	-51.23M	-5.21M	-6.44M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-51.28K	172.44K	-24.5K	756.39K	5.05M	9.69M	21.71M	3.93M	298.03K	5.73M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	44.91K	-274.22K	-714.62K	-480.05K	-20.15M	25.48M	136.51M	35.97M	-8.24M	20.85M
FCF Margin %	-	-	-13.32%	-5.25%	-0.21%	0.09%	0.41%	0.16%	-0.03%	0.04%
FCF Growth %	1.07%	-7.11%	-1.61%	0.33%	-40.98%	2.26%	4.36%	-0.74%	-1.23%	3.53%
FCF per Share	0.02	-0.13	-0.17	-0.07	-4.87	5.94	34.54	8.50	-1.87	4.09
FCF Conversion (FCF/Net Income)	0.54x	0.04x	-1.23x	0.17x	0.58x	0.82x	1.31x	-0.12x	-0.03x	0.44x
Interest Paid	0	0	0	0	427.4K	3.25M	4.1M	4.62M	1.64M	3.47M
Taxes Paid	0	0	0	0	0	181.34K	335.34K	8.23M	849.36K	798.99K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	5.3%	-	24.57%	-645.75%	84.82%	106.93%	78.24%	-272.38%	-45.92%	37.14%
Return on Invested Capital (ROIC)	-28.38%	-	-155.5%	-109.45%	32.03%	52.85%	42.15%	-88.74%	-6.95%	23.56%
Gross Margin	-	-	-952%	31.82%	100%	57.51%	54.08%	7.03%	14.04%	40.89%
Net Margin	-	-	1084.99%	-3079.95%	21.56%	38.67%	39.99%	-193.7%	-18.49%	10.87%
Debt / Equity	-	-	0.16x	-	2.36x	1.02x	0.93x	2.22x	3.49x	1.69x
Interest Coverage	-169.42x	-173.94x	-	-	9.83x	23.81x	27.48x	-32.55x	-1.95x	6.55x
FCF Conversion	0.54x	0.04x	-1.23x	0.17x	0.58x	0.82x	1.31x	-0.12x	-0.03x	0.44x
Revenue Growth	-100%	-	-	70.32%	106120.79%	182.34%	20.98%	-33.85%	12.93%	93.8%

Revenue by Segment

	2022	2023	2024
Hospital Division	198.51M	218.07M	449.06M
Hospital Division Growth	-	9.85%	105.93%

Frequently Asked Questions

Valuation & Price

Nutex Health, Inc. (NUTX) has a price-to-earnings (P/E) ratio of 16.9x. This is roughly in line with market averages.

Growth & Financials

Nutex Health, Inc. (NUTX) reported $981.2M in revenue for fiscal year 2024. This represents a 77382% increase from $1.3M in 2010.

Nutex Health, Inc. (NUTX) grew revenue by 93.8% over the past year. This is strong growth.

Yes, Nutex Health, Inc. (NUTX) is profitable, generating $114.1M in net income for fiscal year 2024 (10.9% net margin).

Dividend & Returns

Yes, Nutex Health, Inc. (NUTX) pays a dividend with a yield of 0.77%. This makes it attractive for income-focused investors.

Nutex Health, Inc. (NUTX) has a return on equity (ROE) of 37.1%. This is excellent, indicating efficient use of shareholder capital.

Nutex Health, Inc. (NUTX) generated $224.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Nutex Health, Inc. (NUTX) 10-Year Financial Performance & Capital Metrics

NUTX • • Industrial / General

HealthcareHealthcare ITClinical Software & EHR SystemsElectronic Health Record Systems

Revenue $480M +93.8%
EBITDA $150M +1154.8%
Net Income $52M +214.0%
EPS (Diluted) 9.71 +193.5%
Gross Margin 40.89% +191.2%
EBITDA Margin 31.17% +644.3%
Operating Margin 27.22% +312.1%
Net Margin 10.87% +158.8%
ROE 37.14% +180.9%
ROIC 23.56% +439.2%
Debt/Equity 1.69 -51.6%
Interest Coverage 6.55 +436.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 20.1%
✓Strong Piotroski F-Score: 7/9
✓Momentum leader: RS Rating 90 (top 10%)
✓Strong 5Y sales CAGR of 37.7%

✗Weaknesses

✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 15.7% in last year

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y68.85%

5Y37.67%

3Y13.12%

TTM236.03%

Profit (Net Income) CAGR

10Y-

5Y20.05%

3Y-26.72%

TTM377.31%

EPS CAGR

10Y-

5Y19.53%

3Y-33.85%

TTM296.53%

ROCE

10Y Avg-41%

5Y Avg8.87%

3Y Avg-29.7%

Latest30.58%

Peer Comparison

Electronic Health Record Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OMCLOmnicell, Inc.	2.29B	50.98	188.81	-3.04%	1.69%	1.63%	6.61%	0.31
NUTXNutex Health, Inc.	1.16B	164.21	16.91	93.8%	11.63%	26.04%	1.8%	1.69
SYSo-Young International Inc.	222.7M	2.65	-0.60	-2.09%	-51.75%	-41.37%		0.12
CCLDCareCloud, Inc.	120.83M	2.85	-10.18	-5.32%	9.8%	19.39%	15.68%	0.07
PHRPhreesia, Inc.	991.72M	16.45	-16.13	17.83%	-1.16%	-1.68%	0.84%	0.07

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	53.65K	91.37K	97.06M	274.03M	331.53M	219.29M	247.65M	479.95M
Revenue Growth %	-1%	-	-	0.7%	1061.21%	1.82%	0.21%	-0.34%	0.13%	0.94%
Cost of Goods Sold+	662	473	564.37K	62.3K	0	116.42M	152.25M	203.87M	212.87M	283.69M
COGS % of Revenue	-	-	10.52%	0.68%	-	0.42%	0.46%	0.93%	0.86%	0.59%
Gross Profit+	-662	-473	-510.72K	29.07K	97.06M	157.61M	179.28M	15.42M	34.77M	196.26M
Gross Margin %	-	-	-9.52%	0.32%	1%	0.58%	0.54%	0.07%	0.14%	0.41%
Gross Profit Growth %	-1%	0.29%	-1078.75%	1.06%	3337.16%	0.62%	0.14%	-0.91%	1.25%	4.64%
Operating Expenses+	532.33K	448.12K	5.69M	1.8M	62.35M	4.43M	9.02M	422.02M	66.55M	65.64M
OpEx % of Revenue	-	-	105.98%	19.67%	0.64%	0.02%	0.03%	1.92%	0.27%	0.14%
Selling, General & Admin	532.33K	448.12K	1.81M	1.16M	59.87M	4.43M	5.46M	20M	36.07M	58.56M
SG&A % of Revenue	-	-	33.81%	12.74%	0.62%	0.02%	0.02%	0.09%	0.15%	0.12%
Research & Development	0	0	25.64K	545.22K	0	0	285.88K	0	0	0
R&D % of Revenue	-	-	0.48%	5.97%	-	-	0%	-	-	-
Other Operating Expenses	0	0	3.87M	633.57K	2.48M	0	3.27M	402.02M	30.48M	7.08M
Operating Income+	-532.99K	-448.6K	-5.69M	-1.83M	34.71M	153.17M	170.26M	-406.6M	-31.77M	130.62M
Operating Margin %	-	-	-106.12%	-20.03%	0.36%	0.56%	0.51%	-1.85%	-0.13%	0.27%
Operating Income Growth %	0.37%	0.16%	-11.69%	0.68%	19.96%	3.41%	0.11%	-3.39%	0.92%	5.11%
EBITDA+	-532.33K	-448.13K	-5.16M	-1.83M	37.19M	159.07M	178.02M	-393.47M	-14.18M	149.59M
EBITDA Margin %	-	-	-96.15%	-20.03%	0.38%	0.58%	0.54%	-1.79%	-0.06%	0.31%
EBITDA Growth %	0.37%	0.16%	-10.51%	0.65%	21.32%	3.28%	0.12%	-3.21%	0.96%	11.55%
D&A (Non-Cash Add-back)	662	473	535.02K	522	2.48M	5.9M	7.76M	13.13M	17.59M	18.97M
EBIT	-532.98K	-448.48K	-5.64M	-840.33K	35.62M	152.17M	175.69M	-407.16M	-32.17M	129.68M
Net Interest Income+	-3.14K	-2.46K	0	0	-3.53M	-6.43M	-6.2M	-12.49M	-16.32M	-19.93M
Interest Income	4	114	0	0	0	0	0	0	0	0
Interest Expense	3.15K	2.58K	-367.35K	-642.07K	3.53M	6.43M	6.2M	12.49M	16.32M	19.93M
Other Income/Expense	-3.14K	-2.46K	-314.55K	-983.68K	-2.62M	-7.43M	-773.88K	-13.05M	-16.72M	-20.87M
Pretax Income+	-536.13K	-451.06K	582.06K	-2.81M	32.09M	145.74M	169.49M	-419.65M	-48.49M	109.75M
Pretax Margin %	-	-	10.85%	-30.8%	0.33%	0.53%	0.51%	-1.91%	-0.2%	0.23%
Income Tax+	0	0	-535.02K	-161.14K	0	181.34K	965.73K	13.09M	-5.07M	14.48M
Effective Tax Rate %	-0.16%	16.48%	1%	1%	0.65%	0.73%	0.78%	1.01%	0.94%	0.48%
Net Income+	83.81K	-7.43M	582.06K	-2.81M	20.92M	105.97M	132.59M	-424.78M	-45.79M	52.18M
Net Margin %	-	-	10.85%	-30.8%	0.22%	0.39%	0.4%	-1.94%	-0.18%	0.11%
Net Income Growth %	1.22%	-89.68%	1.08%	-5.83%	8.43%	4.06%	0.25%	-4.2%	0.89%	2.14%
Net Income (Continuing)	-536.13K	-451.06K	-6.01M	-950.13K	32.09M	145.56M	168.53M	-432.74M	-43.42M	95.27M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	22.53M	61.56M	76.93M	24.46M	17.65M	55.55M
EPS (Diluted)+	0.04	-3.60	0.14	-0.39	3.98	24.69	33.55	-100.36	-10.39	9.71
EPS Growth %	1.13%	-89.67%	1.04%	-3.79%	11.21%	5.2%	0.36%	-3.99%	0.9%	1.93%
EPS (Basic)	0.04	-3.60	0.14	-0.39	3.98	24.69	33.55	-100.50	-10.39	10.23
Diluted Shares Outstanding	2.07M	2.07M	4.18M	7.18M	4.14M	4.29M	3.95M	4.23M	4.41M	5.1M
Basic Shares Outstanding	2.07M	2.07M	4.18M	7.18M	4.14M	4.29M	4.02M	4.23M	4.41M	5.1M
Dividend Payout Ratio	-	-	-	-	0.9%	0.56%	1.09%	-	-	0.12%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	7.63M	507.93K	55.08K	305.42K	45.74M	135.51M	154.02M	97.97M	90.85M	292.48M
Cash & Short-Term Investments	122.29K	10.52K	9.45K	119.27K	8M	25.51M	36.12M	34.26M	22M	43.58M
Cash Only	122.29K	10.52K	9.45K	119.27K	8M	25.51M	36.12M	34.26M	22M	43.58M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	0	15K	6.25K	186.15K	36.14M	108.14M	114.76M	58.32M	62.78M	236.05M
Days Sales Outstanding	-	-	42.55	743.6	135.91	144.04	126.34	97.06	92.52	179.52
Inventory	0	0	0	27.07K	899.91K	1.73M	2.81M	3.53M	3.39M	2.85M
Days Inventory Outstanding	-	-	-	158.62	-	5.41	6.75	6.33	5.81	3.67
Other Current Assets	7.27M	482.41K	39.38K	-27.07K	0	0	323.28K	1.87M	0	10M
Total Non-Current Assets+	3.38K	2.9K	3.27M	144.01K	133.48M	173.05M	240.63M	333.78M	307.4M	362.84M
Property, Plant & Equipment	1.66K	1.18K	3.85K	7.61K	131.28M	170.81M	238.36M	295.15M	269.39M	324.69M
Fixed Asset Turnover	-	-	13.95x	12.00x	0.74x	1.60x	1.39x	0.74x	0.92x	1.48x
Goodwill	0	0	0	0	3.47M	1.14M	1.14M	17.01M	17.07M	13.92M
Intangible Assets	0	0	3.27M	2.57M	1.54M	0	682.65K	21.19M	20.51M	15.53M
Long-Term Investments	0	0	0	116.96K	100K	0	0	0	0	0
Other Non-Current Assets	1.72K	1.72K	1.95K	19.43K	-2.81M	1.1M	456.08K	423.43K	431.13K	711.35K
Total Assets+	7.64M	510.83K	3.33M	449.43K	179.22M	308.55M	394.65M	431.75M	398.25M	655.32M
Asset Turnover	-	-	0.02x	0.20x	0.54x	0.89x	0.84x	0.51x	0.62x	0.73x
Asset Growth %	2.68%	-0.93%	5.52%	-0.86%	397.78%	0.72%	0.28%	0.09%	-0.08%	0.65%
Total Current Liabilities+	6.08M	6.38M	959.78K	1.04M	72.13M	31.45M	37.69M	54.86M	58.31M	140.87M
Accounts Payable	168.97K	356K	348.35K	567.01K	1.75M	8.63M	17.65M	23.93M	25.28M	13.96M
Days Payables Outstanding	93.16K	274.72K	225.3	3.32K	-	27.06	42.32	42.84	43.35	17.96
Short-Term Debt	0	50K	386.19K	477.06K	13.35M	18.65M	10.23M	15.17M	14.18M	17.95M
Deferred Revenue (Current)	811.23K	0	9.1K	9.19K	165.56K	38.65K	173.92K	0	0	0
Other Current Liabilities	5.1M	5.97M	216.14K	332.19K	3.37M	-38.65K	3.6M	5.61M	0	0
Current Ratio	1.26x	0.08x	0.06x	0.29x	0.63x	4.31x	4.09x	1.79x	1.56x	2.08x
Quick Ratio	1.26x	0.08x	0.06x	0.27x	0.62x	4.25x	4.01x	1.72x	1.50x	2.06x
Cash Conversion Cycle	-	-	-	-2.42K	-	122.39	90.77	60.55	54.99	165.22
Total Non-Current Liabilities+	0	0	0	902.72K	56.26M	129.73M	165.38M	256.56M	260.83M	312.56M
Long-Term Debt	0	0	0	902.72K	40.88M	81.9M	78.82M	23.05M	26.31M	22.47M
Capital Lease Obligations	0	0	0	0	15.38M	47.83M	86.56M	223.06M	229.37M	290.1M
Deferred Tax Liabilities	0	0	0	0	0	0	1.75M	10.45M	5.15M	0
Other Non-Current Liabilities	0	0	0	0	0	0	-1.75M	0	0	0
Total Liabilities	6.08M	6.38M	959.78K	1.95M	128.39M	161.19M	203.07M	311.42M	319.14M	453.43M
Total Debt+	0	50K	386.19K	1.38M	119.94M	150.12M	178.55M	267.2M	275.76M	340.3M
Net Debt	-122.29K	39.48K	376.74K	1.26M	111.94M	124.61M	142.43M	232.95M	253.75M	296.72M
Debt / Equity	-	-	0.16x	-	2.36x	1.02x	0.93x	2.22x	3.49x	1.69x
Debt / EBITDA	-	-	-	-	3.23x	0.94x	1.00x	-	-	2.27x
Net Debt / EBITDA	-	-	-	-	3.01x	0.78x	0.80x	-	-	1.98x
Interest Coverage	-169.42x	-173.94x	-	-	9.83x	23.81x	27.48x	-32.55x	-1.95x	6.55x
Total Equity+	1.56M	-5.87M	2.37M	-1.5M	50.84M	147.37M	191.58M	120.33M	79.11M	201.89M
Equity Growth %	-0.03%	-4.76%	1.4%	-1.63%	34.95%	1.9%	0.3%	-0.37%	-0.34%	1.55%
Book Value per Share	0.76	-2.84	0.57	-0.21	12.28	34.34	48.48	28.43	17.94	39.59
Total Shareholders' Equity	1.56M	-5.87M	2.37M	-1.5M	28.31M	85.81M	114.65M	95.86M	61.45M	146.34M
Common Stock	39.68K	39.71K	126.2K	1.77K	4.65K	5.28K	592.79K	650.22K	676.68K	5.51K
Retained Earnings	-2.8M	-10.23M	-9.65M	-5.45M	-12.57M	-18.22M	102.32M	-363.29M	-409.07M	-356.89M
Treasury Stock	0	0	-1M	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	22.53M	61.56M	76.93M	24.46M	17.65M	55.55M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	44.91K	-274.22K	-714.62K	-480.05K	12.12M	86.67M	173.43M	50.61M	1.26M	23.15M
Operating CF Margin %	-	-	-13.32%	-5.25%	0.12%	0.32%	0.52%	0.23%	0.01%	0.05%
Operating CF Growth %	1.07%	-7.11%	-1.61%	0.33%	26.26%	6.15%	1%	-0.71%	-0.98%	17.43%
Net Income	-536.13K	-451.06K	-6.01M	-950.13K	32.09M	145.56M	168.53M	-432.74M	-43.42M	95.27M
Depreciation & Amortization	662	473	535.02K	522	2.48M	5.96M	7.66M	13.13M	17.59M	18.97M
Stock-Based Compensation	0	0	924.33K	208.03K	0	0	0	189.58K	2.84M	16.63M
Deferred Taxes	0	0	-115.22K	-123.43K	0	0	0	5M	-5.71M	-13.13M
Other Non-Cash Items	563.79K	-316.72K	5.52M	-160.67K	-596.94K	1.18M	-5.51M	400.71M	31.62M	9.81M
Working Capital Changes	-116.58K	307K	193.65K	310.99K	-21.85M	-66.02M	2.75M	64.32M	-1.66M	-104.4M
Change in Receivables	56.7K	0	-4K	-82.09K	-24.74M	-71.23M	-6.62M	58.08M	-4.58M	-173.41M
Change in Inventory	0	0	0	127	-486.27K	-825.77K	-1.09M	-719.11K	142.7K	540.77K
Change in Payables	77.79K	187.03K	119.22K	402.25K	1.63M	6.23M	6.27M	9.69M	-2.25M	-10.72M
Cash from Investing+	1.83K	-9.99K	2.05K	-116.96K	-31.23M	-61.19M	-36.98M	-4.34M	-11.24M	-2.67M
Capital Expenditures	0	0	0	0	-32.28M	-61.19M	-36.93M	-14.63M	-9.5M	-2.3M
CapEx % of Revenue	-	-	-	-	0.33%	0.22%	0.11%	0.07%	0.04%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	1.83K	-9.99K	32.85K	0	0	0	0	0	0	0
Cash from Financing+	-51.28K	172.44K	711.5K	704.57K	21.71M	-7.97M	-125.85M	-48.13M	-2.27M	1.09M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	-18.9M	-59.05M	-144.34M	-51.23M	-5.21M	-6.44M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-51.28K	172.44K	-24.5K	756.39K	5.05M	9.69M	21.71M	3.93M	298.03K	5.73M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	44.91K	-274.22K	-714.62K	-480.05K	-20.15M	25.48M	136.51M	35.97M	-8.24M	20.85M
FCF Margin %	-	-	-13.32%	-5.25%	-0.21%	0.09%	0.41%	0.16%	-0.03%	0.04%
FCF Growth %	1.07%	-7.11%	-1.61%	0.33%	-40.98%	2.26%	4.36%	-0.74%	-1.23%	3.53%
FCF per Share	0.02	-0.13	-0.17	-0.07	-4.87	5.94	34.54	8.50	-1.87	4.09
FCF Conversion (FCF/Net Income)	0.54x	0.04x	-1.23x	0.17x	0.58x	0.82x	1.31x	-0.12x	-0.03x	0.44x
Interest Paid	0	0	0	0	427.4K	3.25M	4.1M	4.62M	1.64M	3.47M
Taxes Paid	0	0	0	0	0	181.34K	335.34K	8.23M	849.36K	798.99K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	5.3%	-	24.57%	-645.75%	84.82%	106.93%	78.24%	-272.38%	-45.92%	37.14%
Return on Invested Capital (ROIC)	-28.38%	-	-155.5%	-109.45%	32.03%	52.85%	42.15%	-88.74%	-6.95%	23.56%
Gross Margin	-	-	-952%	31.82%	100%	57.51%	54.08%	7.03%	14.04%	40.89%
Net Margin	-	-	1084.99%	-3079.95%	21.56%	38.67%	39.99%	-193.7%	-18.49%	10.87%
Debt / Equity	-	-	0.16x	-	2.36x	1.02x	0.93x	2.22x	3.49x	1.69x
Interest Coverage	-169.42x	-173.94x	-	-	9.83x	23.81x	27.48x	-32.55x	-1.95x	6.55x
FCF Conversion	0.54x	0.04x	-1.23x	0.17x	0.58x	0.82x	1.31x	-0.12x	-0.03x	0.44x
Revenue Growth	-100%	-	-	70.32%	106120.79%	182.34%	20.98%	-33.85%	12.93%	93.8%

Revenue by Segment

	2022	2023	2024
Hospital Division	198.51M	218.07M	449.06M
Hospital Division Growth	-	9.85%	105.93%

Frequently Asked Questions

Valuation & Price

Nutex Health, Inc. (NUTX) has a price-to-earnings (P/E) ratio of 16.9x. This is roughly in line with market averages.

Growth & Financials

Nutex Health, Inc. (NUTX) reported $981.2M in revenue for fiscal year 2024. This represents a 77382% increase from $1.3M in 2010.

Nutex Health, Inc. (NUTX) grew revenue by 93.8% over the past year. This is strong growth.

Yes, Nutex Health, Inc. (NUTX) is profitable, generating $114.1M in net income for fiscal year 2024 (10.9% net margin).

Dividend & Returns

Yes, Nutex Health, Inc. (NUTX) pays a dividend with a yield of 0.77%. This makes it attractive for income-focused investors.

Nutex Health, Inc. (NUTX) has a return on equity (ROE) of 37.1%. This is excellent, indicating efficient use of shareholder capital.

Nutex Health, Inc. (NUTX) generated $224.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.